1887

Abstract

For successful establishment of infection and initiation of the replication cycle, murine cytomegalovirus (MCMV) utilizes cellular structures and functions, including cell-membrane penetration, capsid dismantling and cytosolic transport of viral DNA into the nucleus. These early events of MCMV infections are dependent on cellular regulatory mechanisms, primarily protein phosphorylation. In the present study, protein kinase inhibitors were used to explore the role of protein phosphorylation mediated by protein kinases C (PKCs) in the very early events of MCMV infection. Inhibitory effects were determined by immunofluorescence and Western blot analysis of MCMV IE1 and E1 protein expression and by production of infectious virions in cell culture. It was found that H-7, a broadly specific inhibitor of cellular protein kinases, prevented virus replication in a dose-dependent and reversible manner, and that the block in replication occurred very early in infection. More specific PKC inhibitors (sangivamycin, calphostin C and bisindolylmaleimide II), Ca/calmodulin inhibitors (EDTA and W7) and phorbol esters (PMA) were used to dissect PKC-subclass contribution in the very early events of MCMV replication. The results indicate that the role of diacylglycerol/phorbol ester-dependent but calcium-independent PKCs is essential for establishment of MCMV infection in the host cell, starting at a very early stage of infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80733-0
2005-08-01
2019-11-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/8/vir862153.html?itemId=/content/journal/jgv/10.1099/vir.0.80733-0&mimeType=html&fmt=ahah

References

  1. Basu, A. ( 1998; ). The involvement of novel protein kinase C isozymes in influencing sensitivity of breast cancer MCF-7 cells to tumor necrosis factor-α. Mol Pharmacol 53, 105–111.
    [Google Scholar]
  2. Bühler, B., Keil, G. M., Weiland, F. & Koszinowski, U. H. ( 1990; ). Characterization of the murine cytomegalovirus early transcription unit e1 that is induced by immediate-early proteins. J Virol 64, 1907–1919.
    [Google Scholar]
  3. Campbell, E. M. & Hope, T. J. ( 2003; ). Role of the cytoskeleton in nuclear import. Adv Drug Deliv Rev 55, 761–771.[CrossRef]
    [Google Scholar]
  4. Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U. & Nishizuka, Y. ( 1982; ). Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257, 7847–7851.
    [Google Scholar]
  5. Constantinescu, S. N., Cernescu, C. D. & Popescu, L. M. ( 1991; ). Effects of protein kinase C inhibitors on viral entry and infectivity. FEBS Lett 292, 31–33.[CrossRef]
    [Google Scholar]
  6. Davis, P. D., Elliott, L. H., Harris, W. & 7 other authors ( 1992; ). Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity. J Med Chem 35, 994–1001.[CrossRef]
    [Google Scholar]
  7. Engh, R. A., Girod, A., Kinzel, V., Huber, R. & Bossemeyer, D. ( 1996; ). Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. J Biol Chem 271, 26157–26164.[CrossRef]
    [Google Scholar]
  8. Hidaka, H. & Kobayashi, R. ( 1992; ). Pharmacology of protein kinase inhibitors. Annu Rev Pharmacol Toxicol 32, 377–397.[CrossRef]
    [Google Scholar]
  9. Hidaka, H., Inagaki, M., Kawamoto, S. & Sasaki, Y. ( 1984; ). Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23, 5036–5041.[CrossRef]
    [Google Scholar]
  10. Inagaki, M., Tanaka, T. & Hidaka, H. ( 1983; ). Calmodulin antagonists enhance calcium binding to calmodulin. Pharmacology 27, 125–129.[CrossRef]
    [Google Scholar]
  11. Keay, S. & Baldwin, B. R. ( 1996; ). Evidence for the role of cell protein phosphorylation in human cytomegalovirus/host cell fusion. J Gen Virol 77, 2597–2604.[CrossRef]
    [Google Scholar]
  12. Keenan, C. & Kelleher, D. ( 1998; ). Protein kinase C and the cytoskeleton. Cell Signal 10, 225–232.[CrossRef]
    [Google Scholar]
  13. Kobayashi, E., Nakano, H., Morimoto, M. & Tamaoki, T. ( 1989; ). Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 159, 548–553.[CrossRef]
    [Google Scholar]
  14. Krajcsi, P. & Wold, W. S. M. ( 1998; ). Viral proteins that regulate cellular signalling. J Gen Virol 79, 1323–1335.
    [Google Scholar]
  15. Loomis, C. R. & Bell, R. M. ( 1988; ). Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C. J Biol Chem 263, 1682–1692.
    [Google Scholar]
  16. Lučin, P. & Jonjić, S. ( 1995; ). Cytomegalovirus replication cycle: an overview. Period Biol 97, 13–22.
    [Google Scholar]
  17. Lučin, P., Jonjić, S., Messerle, M., Polić, B., Hengel, H. & Koszinowski, U. H. ( 1994; ). Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J Gen Virol 75, 101–110.[CrossRef]
    [Google Scholar]
  18. Mettenleiter, T. C. ( 2002; ). Herpesvirus assembly and egress. J Virol 76, 1537–1547.[CrossRef]
    [Google Scholar]
  19. Miller, N. & Hutt-Fletcher, L. M. ( 1992; ). Epstein-Barr virus enters B cells and epithelial cells by different routes. J Virol 66, 3409–3414.
    [Google Scholar]
  20. Muranyi, W., Haas, J., Wagner, M., Krohne, G. & Koszinowski, U. H. ( 2002; ). Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina. Science 297, 854–857.[CrossRef]
    [Google Scholar]
  21. Newton, A. C. ( 1997; ). Regulation of protein kinase C. Curr Opin Cell Biol 9, 161–167.[CrossRef]
    [Google Scholar]
  22. O'Brian, C. A. & Ward, N. E. ( 1989; ). Binding of protein kinase C to N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide through its ATP binding site. Biochem Pharmacol 38, 1737–1742.[CrossRef]
    [Google Scholar]
  23. Parekh, D. B., Ziegler, W. & Parker, P. J. ( 2000; ). Multiple pathways control protein kinase C phosphorylation. EMBO J 19, 496–503.[CrossRef]
    [Google Scholar]
  24. Parker, P. J. & Murray-Rust, J. ( 2004; ). PKC at a glance. J Cell Sci 117, 131–132.[CrossRef]
    [Google Scholar]
  25. Quick, J., Ware, J. A. & Driedger, P. E. ( 1992; ). The structure and biological activities of the widely used protein kinase inhibitor, H7, differ depending on the commercial source. Biochem Biophys Res Commun 187, 657–663.[CrossRef]
    [Google Scholar]
  26. Redman, C., Lefevre, J. & MacDonald, M. L. ( 1995; ). Inhibition of diacylglycerol kinase by the antitumor agent calphostin C: evidence for similarity between the active site of diacylglycerol kinase and the regulatory site of protein kinase C. Biochem Pharmacol 50, 235–241.[CrossRef]
    [Google Scholar]
  27. Root, C. N., Wills, E. G., McNair, L. L. & Whittaker, G. R. ( 2000; ). Entry of influenza viruses into cells is inhibited by a highly specific protein kinase C inhibitor. J Gen Virol 81, 2697–2705.
    [Google Scholar]
  28. Siecskarski, S. B. & Whittaker, G. R. ( 2002; ). Dissecting virus entry via endocytosis. J Gen Virol 83, 1535–1545.
    [Google Scholar]
  29. Slobbe-van Drunen, M. E. P., Vossen, R. C. R. M., Couwenberg, F. M. D., Hulsbosch, M. M., Heemskerk, J. W. M., van Dam-Mieras, M. C. E. & Bruggeman, C. A. ( 1997; ). Activation of protein kinase C enchances the infection of endothelial cells by human cytomegalovirus. Virus Res 48, 207–213.[CrossRef]
    [Google Scholar]
  30. Smith, A. E. & Helenius, A. ( 2004; ). How viruses enter animal cells. Science 304, 237–242.[CrossRef]
    [Google Scholar]
  31. Sodeik, B., Ebersold, M. W. & Helenius, A. ( 1997; ). Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J Cell Biol 136, 1007–1021.[CrossRef]
    [Google Scholar]
  32. Tamaoki, T. & Nakano, H. ( 1990; ). Potent and specific inhibitors of protein kinase C of microbial origin. Biotechnology (N Y) 8, 732–735.[CrossRef]
    [Google Scholar]
  33. Toker, A. ( 1998; ). Signaling through protein kinase C. Front Biosci 3, D1134–D1147.
    [Google Scholar]
  34. Toullec, D., Pianetti, P., Coste, H. & 10 other authors ( 1991; ). The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266, 15771–15781.
    [Google Scholar]
  35. Tugizov, S., Maidji, E., Xiao, J. & Pereira, L. ( 1999; ). An acidic cluster in the cytosolic domain of human cytomegalovirus glycoprotein B is a signal for endocytosis from the plasma membrane. J Virol 73, 8677–8688.
    [Google Scholar]
  36. Ward, N. E. & O'Brian, C. A. ( 1992; ). Kinetic analysis of protein kinase C inhibition by staurosporine: evidence that inhibition entails inhibitor binding at a conserved region of the catalytic domain but not competition with substrates. Mol Pharmacol 41, 387–392.
    [Google Scholar]
  37. Wathen, M. W. ( 2002; ). Non-nucleoside inhibitors of herpesviruses. Rev Med Virol 12, 167–178.[CrossRef]
    [Google Scholar]
  38. Way, K. J., Chou, E. & King, G. L. ( 2000; ). Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol Sci 21, 181–187.[CrossRef]
    [Google Scholar]
  39. Wilkinson, S. E., Parker, P. J. & Nixon, J. S. ( 1993; ). Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J 294, 335–337.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80733-0
Loading
/content/journal/jgv/10.1099/vir.0.80733-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error